Showing results (191-200 of 319) with videos related to
Sort By:
Pageof 32
Neurology|June 27, 2008
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PDR Katzenschlager, J Head, A Schrag, et al.Postgraduate Medical Journal|May 1, 1996
Nocturnal and respiratory disturbances in Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)V S De Bruin, C Machado, R S Howard, et al.Brain : a Journal of Neurology|June 26, 2007
Patterns of levodopa response in Parkinson's disease: a clinico-pathological studyP A Kempster, D R Williams, M Selikhova, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2000
An ambulatory dyskinesia monitorA J Manson, P Brown, J D O'Sullivan, et al.Journal of Clinical Psychopharmacology|August 1, 1995
The therapeutic potential of moclobemide, a reversible selective monoamine oxidase A inhibitor in Parkinson's diseaseK Sieradzan, S Channon, C Ramponi, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1993
The metabolic effects of limbic leucotomy in Gilles de la Tourette syndromeG V Sawle, A J Lees, N F Hymas, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1994
Motor response to levodopa in patients with parkinsonian motor fluctuations: a follow-up study over three yearsA J Hughes, J P Frankel, P A Kempster, et al.Annals of Neurology|September 1, 1994
Glutathione-related enzymes in brain in Parkinson's diseaseJ Sian, D T Dexter, A J Lees, et al.Neurology|May 13, 2009
Hyposmia in pure autonomic failureL Silveira-Moriyama, C Mathias, L Mason, et al.Parkinson'S Disease|March 12, 2013
Impact of Duodopa on Quality of Life in Advanced Parkinson's Disease: A UK Case SeriesT Foltynie, C Magee, C James, et al.Pageof 32